Sagespring Wealth Partners LLC Buys 80 Shares of Cardinal Health, Inc. $CAH

Sagespring Wealth Partners LLC grew its position in Cardinal Health, Inc. (NYSE:CAH) by 4.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,768 shares of the company’s stock after purchasing an additional 80 shares during the period. Sagespring Wealth Partners LLC’s holdings in Cardinal Health were worth $297,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CAH. GAMMA Investing LLC increased its holdings in shares of Cardinal Health by 28.4% in the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock worth $965,000 after acquiring an additional 1,549 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Cardinal Health by 15.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 35,790 shares of the company’s stock worth $4,931,000 after purchasing an additional 4,693 shares in the last quarter. Insigneo Advisory Services LLC acquired a new stake in Cardinal Health during the 1st quarter worth approximately $285,000. Kingswood Wealth Advisors LLC lifted its stake in Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock valued at $429,000 after buying an additional 457 shares in the last quarter. Finally, Premier Path Wealth Partners LLC acquired a new position in shares of Cardinal Health in the first quarter valued at approximately $230,000. 87.17% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares in the company, valued at $2,228,728.32. This represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last 90 days. 0.12% of the stock is owned by company insiders.

Cardinal Health Stock Up 2.0%

NYSE:CAH opened at $156.29 on Friday. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The firm has a market capitalization of $37.13 billion, a price-to-earnings ratio of 24.23, a P/E/G ratio of 1.30 and a beta of 0.71. The stock’s 50 day moving average price is $151.88 and its two-hundred day moving average price is $151.72.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a report on Tuesday, August 12th. Evercore ISI decreased their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Finally, Argus set a $189.00 price target on Cardinal Health in a research report on Friday, August 22nd. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.